10 November 2015
Class 4 caution in use
Distribute to pharmacy and hospital ward level
Wockhardt UK Ltd
Amoxicillin Sodium 250mg Powder for Solution for Injection - PL 29831/0010
Amoxicillin Sodium 500mg Powder for Solution for Injection - PL 29831/0012
Amoxicillin Sodium 1g Powder for Solution for Injection - PL 29831/0011
Drug alert number EL (14)A/09 in connection with the above products was issued on 9 July 2014. In
this alert, healthcare professionals treating neonates and infants (below one year old) were asked not to
use Wockhardt Amoxicillin Powder for Solution for Injection (all strengths and all batches) in such
patients. This was a precautionary measure following receipt of a number of reports of extravasation
and injections site reactions.
Since a broader investigation of factors which may have caused this issue is now ongoing within
MHRA, the recommendations in EL (14)A/09 are still applicable. An update will be provided should the
situation change. At this time, there is still no evidence to suggest that these products are defective.
Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter.
Wockhardt UK Ltd - Amoxicillin Sodium 1g, 250mg and 500mg Powder for Solution for Injection
Published 10 November 2015